The long-term use of inhaled tobramycin in patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 1, Issue SUPPL. 2, 2002, Pages 194-198

  Bowman, C M ^a  

^a Division of Pediatric Pulmonology   (United States)

Author keywords

Aerosol antibiotics; Cystic fibrosis; Pseudomonas aeurginosa; TOBI; Tobramycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; DORNASE ALFA; PLACEBO; QUININE SULFATE; TOBRAMYCIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGE; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION ROUTE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FEVER; GRAM NEGATIVE INFECTION; HUMAN; INCIDENCE; INHALATIONAL DRUG ADMINISTRATION; LONG TERM CARE; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL NEBULIZER; MULTICENTER STUDY; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; TIME; TINNITUS; TREATMENT OUTCOME; VOMITING;

EID: 0036889591     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1569-1993(02)00003-6     Document Type: Article

References (3)

1. Frederiksen , Lanng S, Koch C, et al. Improved survival in the Danish center-treated cystic fibrosis patients: result of aggressive treatment. Pediatr Pulmonol 1996;21(3):153-8.
2. Döring G, Conway SP, Heijerman HGM, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Resp J 2000;16:749-67.
3. Ramsey BW, Dorkin HL, Eisenberg JD, et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993;328:1740-6.